Loading…
Niagen Bioscience is projected to rise to $3.48 by 2027, a +3% move from its current price of $3.39. NAGE is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $3.31 | $3.39 | $3.47 | -0.01% |
| Jul 15 | $3.27 | $3.39 | $3.51 | -0.02% |
| Jul 16 | $3.25 | $3.39 | $3.54 | -0.02% |
| Jul 17 | $3.22 | $3.39 | $3.56 | -0.03% |
| Jul 18 | $3.21 | $3.39 | $3.58 | -0.04% |
| Jul 19 | $3.19 | $3.39 | $3.60 | -0.05% |
| Jul 20 | $3.17 | $3.39 | $3.62 | -0.06% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.17 | $3.39 | $3.62 | -0.06% |
| Week 2 | $3.09 | $3.39 | $3.72 | -0.11% |
| Week 3 | $3.02 | $3.38 | $3.79 | -0.17% |
| Week 4 | $2.97 | $3.38 | $3.86 | -0.22% |
| Week 5 | $2.92 | $3.38 | $3.92 | -0.28% |
| Week 6 | $2.88 | $3.38 | $3.97 | -0.34% |
| Week 7 | $2.84 | $3.38 | $4.02 | -0.39% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Niagen Bioscience, Inc. is a bioscience company focused on developing healthy aging products. It operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors, and NAD+, an essential coenzyme that regulates cellular metabolism, and develops and commercializes proprietary ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products.
In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and authorized healthcare practitioners resellers. The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc.
in March 2025. Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.
Niagen Bioscience, Inc. (NAGE) current price is $3.49, with a market cap of $277.96M and a rank of 3589.
The stock’s technical posture is NEUTRAL, with RSI(14) at 50. The 50-day simple moving average is $3.76 and the 200-day simple moving average is $5.58. Near-term support sits at $3.19 and resistance at $3.86. The 30-day price range runs from $2.96 to $4.11, and annualized volatility is 50%.
Forecast-wise, the outlook shifts from NEUTRAL in the near term to BULLISH in the long term. The 2030 forecast shows an avg price of $4.69 with a min of $3.53 and a max of $6.70 (ROI 34.3, sentiment BULLISH). By 2040, the avg price is $8.94 with a min of $5.89 and a max of $14.68 (ROI 156.1, sentiment BULLISH).
In 2050, the avg price is $16.54 with a min of $9.85 and a max of $29.57 (ROI 374, sentiment BULLISH).
A major floor 17.1% below — a decisive break under it would weaken the trend.
The nearest floor, 5.9% below — buyers have tended to step in here.
The nearest ceiling, 13.9% above — a clean break opens room to run.
A major ceiling 54.0% above — clearing it would confirm fresh momentum.
Key NAGE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NAGE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.44 | Sell | $3.42 | Sell |
| MA 10 | $3.39 | Buy | $3.41 | Sell |
| MA 20 | $3.41 | Sell | $3.45 | Sell |
| MA 50 | $3.73 | Sell | $3.74 | Sell |
| MA 100 | $4.26 | Sell | $4.33 | Sell |
| MA 200 | $5.54 | Sell | $5.29 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.46 | Neutral |
| Stoch RSI (14) | 73.45 | Neutral |
| CCI (20) | -17.54 | Neutral |
| Williams %R (14) | -35.48 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 0.30 | Buy |
| Bollinger %B (20,2) | 0.45 | Neutral |
| Stochastic %K (14) | 64.52 | Neutral |
| TRIX (15) | -0.46 | Sell |
| Awesome (5,34) | -0.06 | Sell |
| Ultimate (7,14,28) | 56.15 | Neutral |
| Momentum (10) | 0.08 | Buy |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 3.45 | Sell |
| ADX (14) | 18.34 | Neutral |
| ATR (14) | 0.09 | Info |
In the near term, market sentiment is NEUTRAL. The 30-day trading range is $2.96 to $4.11. The RSI(14) sits at 50, offering little momentum ambiguity. The 50-day SMA is $3.76 while the 200-day SMA is $5.58, indicating the near-term price could face resistance near the $3.86 level after testing support at $3.19.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.19 | $3.39 | $4.12 | 0% | Neutral | |
| $2.79 | $3.48 | $4.57 | +3% | Neutral | |
| $2.87 | $3.67 | $4.98 | +8% | Neutral | |
| $2.95 | $3.85 | $5.37 | +14% | Neutral | |
| $3.38 | $4.49 | $6.41 | +33% | Bullish | |
| $3.72 | $5.02 | $7.31 | +48% | Bullish | |
| $3.94 | $5.40 | $8.01 | +59% | Bullish | |
| $3.91 | $5.44 | $8.19 | +61% | Bullish | |
| $3.81 | $5.38 | $8.22 | +59% | Bullish | |
| $4.03 | $5.76 | $8.92 | +70% | Bullish | |
| $5.61 | $8.52 | $13.98 | +151% | Bullish | |
| $9.37 | $15.71 | $28.06 | +363% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.19 | $3.39 | $4.11 | +0.00% |
| August 2026 | $2.95 | $3.47 | $4.19 | +2.33% |
| September 2026 | $2.84 | $3.37 | $4.10 | -2.98% |
| October 2026 | $2.81 | $3.34 | $4.11 | -0.65% |
| November 2026 | $2.82 | $3.38 | $4.19 | +1.09% |
| December 2026 | $2.75 | $3.30 | $4.12 | -2.22% |
Click any year to see its month-by-month NAGE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect NAGE to range from $3.19 to $4.12 through 2026. The $3.39 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The NAGE price prediction for 2027 points to an average of $3.48 (low $2.79, high $4.57) — a potential gain of +3% on today's $3.39. A consolidation phase looks the most probable path here.
In 2028, NAGE is projected to trade between $2.87 and $4.98, averaging $3.67 — a potential gain of +8% from today's $3.39. That is up +5% on the projected 2027 average. Price action looks broadly range-bound.
Niagen Bioscience's 2029 outlook centres on $3.85, within a $2.95 to $5.37 range. That is up +5% on the projected 2028 average. That marks a +14% change versus current levels. A consolidation phase looks the most probable path here.
By 2030, NAGE could reach as high as $6.41, with a base case around $4.49 and support toward $3.38 — roughly +33% from $3.39. Momentum favours further upside here.
Expect NAGE to range from $3.72 to $7.31 through 2031. The $5.02 average target implies a +48% move from current prices. That is up +12% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The NAGE price prediction for 2032 points to an average of $5.40 (low $3.94, high $8.01) — a potential gain of +59% on today's $3.39. Momentum favours further upside here.
In 2033, NAGE is projected to trade between $3.91 and $8.19, averaging $5.44 — a potential gain of +61% from today's $3.39. That is up +1% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Niagen Bioscience's 2034 outlook centres on $5.38, within a $3.81 to $8.22 range. That is -1% versus the projected 2033 average. That marks a +59% change versus current levels. Momentum favours further upside here.
By 2035, NAGE could reach as high as $8.92, with a base case around $5.76 and support toward $4.03 — roughly +70% from $3.39. Buyers look set to stay in control over this stretch.
Expect NAGE to range from $5.61 to $13.98 through 2040. The $8.52 average target implies a +151% move from current prices. That is up +48% on the projected 2035 average. Momentum favours further upside here.
The NAGE price prediction for 2050 points to an average of $15.71 (low $9.37, high $28.06) — a potential gain of +363% on today's $3.39. Buyers look set to stay in control over this stretch.
Investing $1,000 in NAGE today (≈ 294.985251 NAGE) could be worth
$4,634.5
+$3,634.5 (+363%) by 2050 · US Dollar
Based on the average projected NAGE price of $15.71 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NAGEwould be worth at today's price.
$1,000 invested in NAGE on Jul 10, 2025 (≈ 84.817642 NAGE) would be worth
$287.53
-$712.47 (-71.2%) today · 0.29× · US Dollar
Based on a NAGE entry price of $11.79 vs. today's $3.39.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.43 | $988.34 | -1.2% |
| 1 month ago | $3.47 | $976.95 | -2.3% |
| 3 months ago | $4.5 | $753.33 | -24.7% |
| 6 months ago | $6.39 | $530.52 | -46.9% |
| 1 year ago | $11.79 | $287.53 | -71.2% |
| All time (5.0y) ago | $9.17 | $369.68 | -63.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NAGE forecast.
Our base-case forecast reaches $6.80 around 2040.
Implied market cap at $6.80: $541.58M
The multi-year outlook supports a bullish trajectory from 2030 onward. In 2030, the avg price is $4.69 with a min of $3.53 and a max of $6.70, and the ROI is 34.3 with a bullish sentiment. The 2040 forecast shows an avg of $8.94, min $5.89, max $14.68, and a ROI of 156.1, continuing the bullish stance.
By 2050, the avg is $16.54, min $9.85, max $29.57, with a ROI of 374 and a bullish sentiment. These are estimates and not guarantees; actual outcomes will depend on market and company developments.
Tap a question to reveal the answer.
2030: avg $4.69, min $3.53, max $6.70; ROI 34.3; sentiment BULLISH.
Forecasts show NEUTRAL in 2026-2029, then BULLISH from 2030 onward, with 2030 avg $4.69 and ROI 34.3, 2040 avg $8.94 and ROI 156.1, and 2050 avg $16.54 and ROI 374.
Yes. The 2040 forecast lists a max of $14.68 and an avg of $8.94, indicating potential to exceed $10 in that horizon.
2026: min $3.53, avg $3.49, max $4.24; ROI 0; sentiment NEUTRAL.
2050: min $9.85, avg $16.54, max $29.57; ROI 374; sentiment BULLISH.
Niagen Bioscience Community Discussion
0Share your Niagen Bioscience price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.